Gomes, A. C. http://orcid.org/0000-0002-3974-4088
Baraniak, I. A.
Lankina, A.
Moulder, Z. http://orcid.org/0000-0002-4006-6587
Holenya, P. http://orcid.org/0000-0001-9633-2621
Atkinson, C.
Tang, G. http://orcid.org/0000-0001-7815-6839
Mahungu, T.
Kern, F. http://orcid.org/0000-0002-0368-8408
Griffiths, P. D. http://orcid.org/0000-0001-9317-5915
Reeves, M. B. http://orcid.org/0000-0002-4909-1076
Funding for this research was provided by:
Wellcome Trust (204870/Z/16/Z, 204870/Z/16/Z)
Rosetrees Trust (A1601, A2207)
Article History
Received: 11 June 2021
Accepted: 13 February 2023
First Online: 23 February 2023
Competing interests
: I.B., P.G. and M.R. are co-inventors on WO Patent WO 2022/129937A1 – HCMV vaccine and antibody target that covers the application of AD-6. The other authors declare no competing interests.